These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 29373786)

  • 1. Recent Advances in CRISPR Base Editing: From A to RNA.
    Bjerke JN; Beardslee PC; McNaughton BR
    Biochemistry; 2018 Feb; 57(6):886-887. PubMed ID: 29373786
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR as a strong gene editing tool.
    Shen S; Loh TJ; Shen H; Zheng X; Shen H
    BMB Rep; 2017 Jan; 50(1):20-24. PubMed ID: 27616359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGEN Editing of RNA and DNA: The Long and Winding Road from Catalytic RNAs to CRISPR to the Clinic.
    Sullenger BA
    Cell; 2020 May; 181(5):955-960. PubMed ID: 32470403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric DNA-RNA Guide RNA Designs.
    Lu S; Zhang Y; Yin H
    Methods Mol Biol; 2021; 2162():79-85. PubMed ID: 32926379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
    Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cas14: Big Advances from Small CRISPR Proteins.
    Savage DF
    Biochemistry; 2019 Feb; 58(8):1024-1025. PubMed ID: 30740978
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimization of genome editing through CRISPR-Cas9 engineering.
    Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
    Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reporter does CRISPR.
    Cohen J
    Science; 2016 Nov; 354(6312):541. PubMed ID: 27811249
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene editing and gene regulation with CRISPR.
    Harrison P; Hart S
    Exp Physiol; 2018 Apr; 103(4):437-438. PubMed ID: 29603460
    [No Abstract]   [Full Text] [Related]  

  • 14. CRISPR-Cas9-Guided Genome Engineering in C. elegans.
    Kim HM; Colaiácovo MP
    Curr Protoc Mol Biol; 2016 Jul; 115():31.7.1-31.7.18. PubMed ID: 27366893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Battling CRISPR-Cas9 off-target genome editing.
    Li D; Zhou H; Zeng X
    Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimizing off-target effects in CRISPR-Cas9 genome editing.
    Chen SJ
    Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
    [No Abstract]   [Full Text] [Related]  

  • 17. Keeping our eyes on CRISPR: the "Atlas" of gene editing.
    Wang W; Hou J; Zheng N; Wang X; Zhang J
    Cell Biol Toxicol; 2019 Aug; 35(4):285-288. PubMed ID: 31165372
    [No Abstract]   [Full Text] [Related]  

  • 18. CRISPR-Cas12 and Cas13: the lesser known siblings of CRISPR-Cas9.
    Yan F; Wang W; Zhang J
    Cell Biol Toxicol; 2019 Dec; 35(6):489-492. PubMed ID: 31468291
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the CRISPR genome editing tool set.
    Moon SB; Kim DY; Ko JH; Kim YS
    Exp Mol Med; 2019 Nov; 51(11):1-11. PubMed ID: 31685795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.